Key players in Epilepsy Drugs
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Abbott Laboratories | — | 2,310 reports |
| 2 |  GSK PLC |
gsk.com (opens in a new tab) | 1,254 reports |
| 3 |  Johnson & Johnson Health Care Systems Inc. |
jnj.com (opens in a new tab) | 33 reports |
| 4 |  Novartis AG |
novartis.com (opens in a new tab) | 1,551 reports |
| 5 | UCB | — | 231 reports |
| 6 |  Pfizer Inc. |
pfizer.com (opens in a new tab) | 2,310 reports |
| 7 | Bausch Health Companies Inc. | — | 165 reports |
| 8 |  Teva Pharmaceutical |
tevapharm.com (opens in a new tab) | 462 reports |
| 9 |  Sunovion Pharmaceuticals Inc. |
sunovion.com (opens in a new tab) | 33 reports |
| 10 | Eisai Co. | — | 132 reports |
Also active in Epilepsy Drugs
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| Praxis Precision Medicines |
|
| Zydus Lifesciences | |
 Aurobindo Pharma |
|
| Jazz Pharmaceuticals |
|
| Rapport Therapeutics Inc. |
|
| Taro | |
| Alkem Laboratories Ltd | |
| Xenon Pharmaceuticals Inc. |
|
| Encoded Therapeutics |
|
 Glenmark Pharmaceuticals |
|
 Amneal Pharmaceuticals, Inc |
|
| Biohaven |
|
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Epilepsy Drugs
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Praxis Precision Medicines 6 active trials on ClinicalTrials.gov (opens in a new tab)
- Jazz Pharmaceuticals 5 active trials on ClinicalTrials.gov (opens in a new tab)
- Rapport Therapeutics Inc. 4 active trials on ClinicalTrials.gov (opens in a new tab)
- Xenon Pharmaceuticals Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Encoded Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Biohaven 3 active trials on ClinicalTrials.gov (opens in a new tab)
- UCB Biopharma SRL 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Ono Pharmaceutical Co., Ltd. 3 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Epilepsy Drugs reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Epilepsy Drugs report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.